metsera glp-1 Is This the First Real Threat to Lilly and Novo? Metsera's Stunning New Data for Once Monthly Amylin Agonist Metsera touts long-acting GLP-1 drug;

Description

Final Thoughts Injection site reactions are common but preventable

Recorded live at the #SCDAA convention in Chicago

GLP-1 appetite suppression is unpredictable

Weight management success depends primarily on caloric intake, physical activity, and hormonal regulation

Access this article Similar content being viewed by others Abbreviations Anti-TNF: Anti-tumor necrosis factor- Anti-IL12 and anti-IL23: Anti-interleukin-12 and anti-interleukin-23 c-AMP: Cyclic adenosine monophosphate CD: Crohns disease CDAI: Crohns Disease Activity Index DNA: Deoxy-ribonucleic acid DPP-4: Dipeptidyl peptidase-4 EGF: Epidermal growth factor ESPEN: European Society for Clinical Nutrition and Metabolism GE: Gastric emptying GI: Gastrointestinal GLP-2: Glucagon-like peptide-2 GLP-2R: Glucagon-like peptide 2 receptor GIP: Glucose-dependent insulinotropic polypeptide GRPP: Glicentin-related pancreatic peptide IBD: Inflammatory bowel disease IGF-1: Insulin-like growth factor-1 IVS: Intravenous supplementation KGF: Keratinocyte growth factor nNOS: Neuronal nitric oxide synthase PC: Pro-hormone convertase PGDP: Pro-glucagon-derived peptide PKA: Protein kinase A PS: Parenteral support QoL: Quality of life SBS-IF: Short bowel syndrome-intestinal failure SC: Subcutaneous SGLT-1: Sodium-glucose transporter-1 T2DM: Diabetes mellitus type 2 References Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance Seige K